Physician Preferences for Extra-Glycemic Effects of Type 2 Diabetes Treatments

Physician Preferences for Extra-Glycemic Effects of Type 2 Diabetes Treatments

INTRODUCTION The purpose of this study was to quantify United States (US) and United Kingdom (UK) physicians' preferences for attributes of type 2 diabetes treatments. METHODS Samples of general practitioners (GPs) and endocrinologists in the US (n = 204) and the UK (n = 200) completed a discrete-choice experiment in which respondents chose between pairs of hypothetical type 2 diabetes treatm...

Treatments for Type 2 Diabetes

G lucagon-like peptide-1 (GLP-1) is produced by the proglucagon gene in L-cells of the small intestine in response to nutrients.1 It is an incretin – a gut hormone – that is responsible for the greater insulin response to oral versus IV glucose.2 Its major mechanism of action occurs through stimulation of glucose-dependent insulin release from the pancreatic islets. In addition to its insulinot...

A Review of the Relationship between Dietary Glycemic Index and Glycemic Load and Type 2 Diabetes

Background: In recent decades, studies on type 2 diabetes (T2D), have adopted a new approach to the field of a more complete collection of variables related to the lifestyles and diet of people. Diet is an important factor in increasing the rate of T2D among individuals. Considering the consumption of a high-carbohydrate diet, little attention has been paid to the type of carbohydrates consumed...

Type 2 Diabetes, Iron, Exercise Therapy, Glycemic Control

Background and aims: Previous research has shown that one of the factors associated with type II diabetes and insulin resistance is impaired iron metabolism; also, one of the elemental keys in type II diabetes is regular exercise. The aim of this study was to evaluate the effect of moderate intensity body pump training on iron-related indices in women with type II diabetes. Methods: In the pr...

Novel treatments for type 2 diabetes.